Mark Gruppetta

688 total citations
31 papers, 399 citations indexed

About

Mark Gruppetta is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Mark Gruppetta has authored 31 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 7 papers in Genetics. Recurrent topics in Mark Gruppetta's work include Pituitary Gland Disorders and Treatments (9 papers), Adrenal and Paraganglionic Tumors (8 papers) and Diabetes and associated disorders (4 papers). Mark Gruppetta is often cited by papers focused on Pituitary Gland Disorders and Treatments (9 papers), Adrenal and Paraganglionic Tumors (8 papers) and Diabetes and associated disorders (4 papers). Mark Gruppetta collaborates with scholars based in Malta and United Kingdom. Mark Gruppetta's co-authors include Josanne Vassallo, Cecilia Mercieca, Stephen Fava, Neville Calleja, Angela Xuereb‐Anastasi, Jane Clark, Christopher Rizzo, Alex E. Felice, Matthew Mercieca Balbi and Nikolai Paul Pace and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Endocrinology and Clinical Cardiology.

In The Last Decade

Mark Gruppetta

29 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Gruppetta Malta	9	280	152	78	66	46	31	399
Nigel Glynn Ireland	12	282 1.0×	112 0.7×	81 1.0×	77 1.2×	36 0.8×	24	394
Dima Abdelmannan United States	11	424 1.5×	165 1.1×	52 0.7×	76 1.2×	29 0.6×	25	575
M. J. THOMSETT Australia	14	412 1.5×	140 0.9×	59 0.8×	95 1.4×	89 1.9×	28	536
F. Chentli Algeria	9	189 0.7×	71 0.5×	50 0.6×	27 0.4×	35 0.8×	54	314
Nazlı Gönç Türkiye	12	192 0.7×	57 0.4×	28 0.4×	23 0.3×	137 3.0×	38	435
Erkan Sarı Türkiye	10	103 0.4×	70 0.5×	66 0.8×	18 0.3×	53 1.2×	22	350
Marie-Annick Dugué France	7	384 1.4×	206 1.4×	35 0.4×	38 0.6×	15 0.3×	13	479
Anil Bhansali India	12	122 0.4×	82 0.5×	37 0.5×	15 0.2×	66 1.4×	41	362
Elisabetta Lavezzi Italy	12	334 1.2×	100 0.7×	83 1.1×	8 0.1×	49 1.1×	28	555
William P. Martin Ireland	12	98 0.3×	126 0.8×	50 0.6×	24 0.4×	59 1.3×	37	411

Countries citing papers authored by Mark Gruppetta

Since Specialization

Citations

This map shows the geographic impact of Mark Gruppetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gruppetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gruppetta more than expected).

Fields of papers citing papers by Mark Gruppetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gruppetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gruppetta. The network helps show where Mark Gruppetta may publish in the future.

Co-authorship network of co-authors of Mark Gruppetta

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gruppetta. A scholar is included among the top collaborators of Mark Gruppetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gruppetta. Mark Gruppetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vassallo, Josanne, et al.. (2025). Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective. PubMed. 5(1). e250039–e250039.

Gruppetta, Mark, et al.. (2023). Thiazide diuretics and primary hyperparathyroidism. British Journal of Hospital Medicine. 84(12). 1–8. 1 indexed citations

Gruppetta, Mark, et al.. (2022). Immobilisation hypercalcaemia. British Journal of Hospital Medicine. 83(6). 1–7. 1 indexed citations

Vassallo, Josanne, et al.. (2022). Epidemiology and blood parameter changes in Cushing’s syndrome — a population-based study. HORMONES. 21(3). 467–476. 5 indexed citations

Gruppetta, Mark, et al.. (2022). Inpatient hyperglycaemia, and impact on morbidity, mortality and re-hospitalisation rates. Clinical Medicine. 22(4). 325–331. 6 indexed citations

Gruppetta, Mark, et al.. (2022). Hyperglycaemia and inpatient mortality and morbidity. Clinical Medicine. 22(4). 12–13. 4 indexed citations

Gruppetta, Mark, et al.. (2021). Cotrimoxazole-induced hyperkalaemia in a patient with known hypoaldosteronism. BMJ Case Reports. 14(3). e239543–e239543. 1 indexed citations

Gruppetta, Mark, et al.. (2021). Adrenal insufficiency in HIV/AIDS: a review. Expert Review of Endocrinology & Metabolism. 16(6). 351–362. 6 indexed citations

Gruppetta, Mark, et al.. (2021). Biochemically silent phaeochromocytoma presenting with non-specific loin pain. BMJ Case Reports. 14(8). e244258–e244258. 4 indexed citations

10.

Gruppetta, Mark, et al.. (2020). Clinical reasoning: exploring its characteristics and enhancing its learning. British Journal of Hospital Medicine. 81(10). 1–9. 11 indexed citations

11.

Gruppetta, Mark, et al.. (2020). Lithium-associated hyperparathyroidism. British Journal of Hospital Medicine. 81(11). 1–9. 17 indexed citations

12.

Gruppetta, Mark, et al.. (2020). Sodium-glucose co-transporter 2 (SGLT2) inhibitors. OAR@UM (University of Malta). 9 indexed citations

13.

Gruppetta, Mark, et al.. (2020). A current perspective into young female sex hormone replacement: a review. Expert Review of Endocrinology & Metabolism. 15(6). 405–414. 3 indexed citations

14.

Pace, Nikolai Paul, Christopher Rizzo, Mark Gruppetta, et al.. (2019). Identification of an HNF1A p.Gly292fs Frameshift Mutation Presenting as Diabetes During Pregnancy in a Maltese Family. Clinical Medicine Insights Case Reports. 12. 3571461370–3571461370. 5 indexed citations

15.

Gruppetta, Mark, et al.. (2018). Stress-induced hyperglycaemia. British Journal of Hospital Medicine. 79(11). 634–639. 72 indexed citations

16.

Balbi, Matthew Mercieca, et al.. (2018). Beer, hyponatraemia and cardiac conduction defects. BMJ Case Reports. 2018. bcr–2018. 3 indexed citations

17.

Gruppetta, Mark, et al.. (2016). Carbimazole-induced exudative pleural effusions. BMJ Case Reports. 2016. bcr2016215080–bcr2016215080. 6 indexed citations

18.

Gruppetta, Mark, et al.. (2012). Prevalence and incidence of pituitary adenomas; a population based study in Malta. 15th International & 14th European Congress of Endocrinology. 29. 3 indexed citations

19.

Gruppetta, Mark, et al.. (2012). Expression and Clinical Significance of Wnt Players and Survivin in Pituitary Tumours. Endocrine Pathology. 23(2). 123–131. 19 indexed citations

20.

Gruppetta, Mark, Neville Calleja, & Stephen Fava. (2010). Long‐Term Survival After Acute Myocardial Infarction and Relation to Type 2 Diabetes and Other Risk Factors. Clinical Cardiology. 33(7). 424–429. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact